129 results
Page 3 of 7
8-K
EX-99.2
k0by9sp1z3d7ot
15 Apr 20
Securities Purchase Agreement
12:00am
8-K
EX-99.2
nvi9gk3fonfrog6asw
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-99.1
6yabw9
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-5.1
e183mp5 pxgnkwkebdlr
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-99.3
wpq7 ukvuh5ix1x
5 Mar 20
Securities Purchase Agreement
4:45pm
424B5
hgxd p3jw07lu1rnzq4j
5 Mar 20
Prospectus supplement for primary offering
8:46am
8-K
EX-99.3
pie00y15hcifo0bd
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-99.2
usrsimybbsjait484
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-5.1
opuf5
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-99.1
e3ku1rocii7hwwffvro
3 Mar 20
Securities Purchase Agreement
4:40pm
424B5
5zzxj0lobm7db1s4
2 Mar 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-4.2
uvasyy1p8s ulhsjju
9 Jan 20
Entry into a Material Definitive Agreement
8:40am
8-K
EX-5.1
sxklc6f6w
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
8-K
5i7d dex01
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
8-K
EX-4.1
re2w o7m81gzpwv
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am